Liu, P., Tang, H., Wu, J., Kong, Y., Zhang, L., Xie, X., & Xiao, X. (2019). Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer. Curr Cancer Drug Targets.
Citación estilo ChicagoLiu, Peng, Hailin Tang, Jiali Wu, Yanan Kong, Lijuan Zhang, Xinhua Xie, y Xiangsheng Xiao. "Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer." Curr Cancer Drug Targets 2019.
Cita MLALiu, Peng, et al. "Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer." Curr Cancer Drug Targets 2019.
Precaución: Estas citas no son 100% exactas.